156 related articles for article (PubMed ID: 11524136)
1. Effect of onion consumption by rats on hepatic drug-metabolizing enzymes.
Teyssier C; Amiot MJ; Mondy N; Auger J; Kahane R; Siess MH
Food Chem Toxicol; 2001 Oct; 39(10):981-7. PubMed ID: 11524136
[TBL] [Abstract][Full Text] [Related]
2. Effects of a water-soluble extract of rosemary and its purified component rosmarinic acid on xenobiotic-metabolizing enzymes in rat liver.
Debersac P; Vernevaut MF; Amiot MJ; Suschetet M; Siess MH
Food Chem Toxicol; 2001 Feb; 39(2):109-17. PubMed ID: 11267703
[TBL] [Abstract][Full Text] [Related]
3. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
[TBL] [Abstract][Full Text] [Related]
4. Induction of cytochrome P450 and/or detoxication enzymes by various extracts of rosemary: description of specific patterns.
Debersac P; Heydel JM; Amiot MJ; Goudonnet H; Artur Y; Suschetet M; Siess MH
Food Chem Toxicol; 2001 Sep; 39(9):907-18. PubMed ID: 11498267
[TBL] [Abstract][Full Text] [Related]
5. Effect of bitter melon (Momordica charantia) fruit juice on the hepatic cytochrome P450-dependent monooxygenases and glutathione S-transferases in streptozotocin-induced diabetic rats.
Raza H; Ahmed I; Lakhani MS; Sharma AK; Pallot D; Montague W
Biochem Pharmacol; 1996 Nov; 52(10):1639-42. PubMed ID: 8937480
[TBL] [Abstract][Full Text] [Related]
6. Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides.
Siess MH; Le Bon AM; Canivenc-Lavier MC; Suschetet M
Cancer Lett; 1997 Dec; 120(2):195-201. PubMed ID: 9461037
[TBL] [Abstract][Full Text] [Related]
7. Narcotic drugs change the expression of cytochrome P450 2E1 and 2C6 and other activities of carcinogen-metabolizing enzymes in the liver of male mice.
Sheweita SA
Toxicology; 2003 Sep; 191(2-3):133-42. PubMed ID: 12965116
[TBL] [Abstract][Full Text] [Related]
8. Effects of Bu-Zhong-Yi-Qi-Tang on hepatic drug-metabolizing enzymes and plasma tolbutamide concentration in rats.
Yao HT; Chang YW; Uramaru N; Watanabe Y; Kitamura S; Kuo YH; Lii CK; Yeh TK
J Ethnopharmacol; 2012 Jun; 142(1):121-8. PubMed ID: 22564357
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver.
Canivenc-Lavier MC; Vernevaut MF; Totis M; Siess MH; Magdalou J; Suschetet M
Toxicology; 1996 Nov; 114(1):19-27. PubMed ID: 8931757
[TBL] [Abstract][Full Text] [Related]
10. Selective induction of phase II drug metabolizing enzyme activities by quinolines and isoquinolines.
Le HT; Franklin MR
Chem Biol Interact; 1997 Mar; 103(3):167-78. PubMed ID: 9134007
[TBL] [Abstract][Full Text] [Related]
11. Modulation of phase II enzymes by organosulfur compounds from allium vegetables in rat tissues.
Guyonnet D; Siess MH; Le Bon AM; Suschetet M
Toxicol Appl Pharmacol; 1999 Jan; 154(1):50-8. PubMed ID: 9882591
[TBL] [Abstract][Full Text] [Related]
12. Effects of chitosan oligosaccharides on drug-metabolizing enzymes in rat liver and kidneys.
Yao HT; Luo MN; Hung LB; Chiang MT; Lin JH; Lii CK; Huang CY
Food Chem Toxicol; 2012 May; 50(5):1171-7. PubMed ID: 22386817
[TBL] [Abstract][Full Text] [Related]
13. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
[TBL] [Abstract][Full Text] [Related]
14. Differential induction of carcinogen metabolizing enzymes in a transgenic mouse model of fulminant hepatitis.
Chemin I; Takahashi S; Belloc C; Lang MA; Ando K; Guidotti LG; Chisari FV; Wild CP
Hepatology; 1996 Sep; 24(3):649-56. PubMed ID: 8781338
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug.
Brandon EF; Sparidans RW; van Ooijen RD; Meijerman I; Lazaro LL; Manzanares I; Beijnen JH; Schellens JH
Invest New Drugs; 2007 Feb; 25(1):9-19. PubMed ID: 16633717
[TBL] [Abstract][Full Text] [Related]
16. Phase II-selective induction of hepatic drug-metabolizing enzymes by oltipraz -5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione-, 1,7-phenanthroline, and 2,2'-dipyridyl in rats is not accompanied by induction of intestinal enzymes.
Vargas M; Lamb JG; Franklin MR
Drug Metab Dispos; 1998 Feb; 26(2):91-7. PubMed ID: 9456293
[TBL] [Abstract][Full Text] [Related]
17. Detoxifying activity in pig livers and hepatocytes intended for xenotherapy.
Desille M; Corcos L; L'Helgoualc'h A; Frémond B; Campion JP; Guillouzo A; Clément B
Transplantation; 1999 Nov; 68(10):1437-43. PubMed ID: 10589936
[TBL] [Abstract][Full Text] [Related]
18. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism.
Moon YJ; Wang X; Morris ME
Toxicol In Vitro; 2006 Mar; 20(2):187-210. PubMed ID: 16289744
[TBL] [Abstract][Full Text] [Related]
19. Effects of neem flowers, Thai and Chinese bitter gourd fruits and sweet basil leaves on hepatic monooxygenases and glutathione S-transferase activities, and in vitro metabolic activation of chemical carcinogens in rats.
Kusamran WR; Ratanavila A; Tepsuwan A
Food Chem Toxicol; 1998 Jun; 36(6):475-84. PubMed ID: 9674955
[TBL] [Abstract][Full Text] [Related]
20. Induction of NAD(P)H quinone oxidoreductase and glutathione S-transferase activities in livers of female August-Copenhagen Irish rats treated chronically with estradiol: comparison with the Sprague-Dawley rat.
Sanchez RI; Mesia-Vela S; Kauffman FC
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):199-206. PubMed ID: 14672740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
